The New York TimesMDMA Therapy for PTSD Inches Closer to U.S. ApprovalSep 26, 2023Rachel NuwerBy Rachel Nuwermore_vert
UC San FranciscoMDMA's Latest Trial Results Offer Hope for Patients with PTSDSep 13, 2023Victoria ColliverBy Victoria Collivermore_vert
Fox NewsStudy on MDMA's use to treat PTSD could send therapy method to FDA for approval by 2024Sep 18, 2023Greg WehnerBy Greg Wehnermore_vert
The Associated PressPsychedelic drug MDMA eases PTSD symptoms in a study that paves the way for possible US approvalSep 14, 2023Carla JohnsonBy Carla Johnsonmore_vert
Los Angeles TimesMDMA-assisted therapy could soon be approved by the FDA. Will insurance cover it?Sep 19, 2023Laura Allison NewberryBy Laura Allison Newberrymore_vert
Multidisciplinary Association for Psychedelic Studies - MAPSMAPS PBC Publishes Results of Successful Confirmatory Phase 3 Trial of MDMA-Assisted Therapy for PTSDSep 13, 2023more_vert
Nature.comMDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trialSep 14, 2023Marcela Ot'alora, Michael Bogenschutz & Yevgeniy GelfandBy Marcela Ot'alora, Michael Bogenschutz & Yevgeniy Gelfandmore_vert
New ScientistMDMA therapy for PTSD expected to get US approval after latest trialSep 14, 2023Jason Arunn MurugesuBy Jason Arunn Murugesumore_vert